Patients typically need a Body Mass Index (BMI) of 35 or higher, with obesity-related health conditions, or a BMI of 40 or more to qualify for gastric sleeve surgery. This surgery, known as Vertical Sleeve Gastrectomy (VSG), involves removing about 80% of the stomach to reduce food intake and is one of the most popular bariatric procedures.

In medical terms, GI stands for Gastrointestinal, referring to the digestive system, which includes the stomach, intestines, and other associated organs. GI disorders encompass a wide range of conditions that affect digestion, including gastritis, irritable bowel syndrome (IBS), and gastrointestinal cancers.

After Vertical Sleeve Gastrectomy (VSG), patients must follow a strict diet to ensure the stomach heals properly and to promote weight loss. The post-op diet begins with liquids and progresses to soft foods, and eventually solids. It emphasizes protein intake, hydration, and portion control to avoid complications like vomiting or nutrient deficiencies.

A gastric band fill is a procedure where saline is added to the adjustable band around the stomach to tighten it, reducing the stomach's capacity and limiting food intake. The fill is performed through a port placed under the skin and can be adjusted based on the patient’s progress and needs. Fills are crucial for regulating how much food can pass through the stomach, ensuring consistent weight loss.

Endoscopic Sleeve Gastroplasty (ESG) is a non-surgical weight-loss procedure where a gastroenterologist uses an endoscope to stitch the stomach into a smaller size, reducing its capacity. Unlike traditional bariatric surgery, ESG is performed through the mouth and doesn’t involve cutting or removing any part of the stomach. Recovery is quicker, and the procedure is reversible, but the weight loss achieved is typically less significant than with RNY or gastric sleeve surgery.

Bariatric refers to the branch of medicine that deals with the causes, prevention, and treatment of obesity. Bariatric surgery includes weight-loss procedures like gastric bypass, sleeve gastrectomy, and lap band surgery, which help patients lose significant amounts of weight and improve obesity-related health conditions.

Cancer of the Gastrointestinal Tract (GIT) includes cancers that affect the stomach, intestines, esophagus, colon, liver, and pancreas. Symptoms vary depending on the type of cancer but may include weight loss, blood in the stool, or persistent abdominal pain. Early detection is crucial for improving survival rates, and treatment options range from surgery to chemotherapy and radiation.

Slimming injections like Wegovy or Saxenda are used to assist with weight loss by controlling appetite and hunger. These injections are prescribed for individuals who struggle with obesity or weight-related health issues and have not been able to lose weight through diet and exercise alone.

The NHS in the UK has started prescribing Wegovy to patients who struggle with obesity and have failed to achieve significant weight loss through diet and exercise. This medication is part of a broader initiative to provide patients with additional tools to combat the obesity epidemic. Wegovy is typically prescribed alongside lifestyle changes to maximize its effectiveness.

Atrophic gastritis is a chronic condition where the stomach lining thins and loses its ability to produce stomach acid and digestive enzymes. This condition can be caused by long-term H. pylori infection or autoimmune diseases and may increase the risk of stomach cancer. Treatment focuses on addressing the underlying cause and managing symptoms.

Weight loss helpers include various tools and strategies designed to support weight loss, such as meal planning apps, fitness trackers, supplements, and professional guidance from nutritionists or personal trainers. These aids can provide structure, motivation, and accountability for individuals on their weight-loss journey.